RC
Repligen Corporation
RGEN· Health Care· BiotechnologyS&P 400
Close · 26/10/2026
180.17
1D
+1.83%52-week range
100.99 – 198.87
Volume
11,77,400.00
Price history
RGEN
25/09/2026 to 26/10/2026
O 176.93 H 181.46 L 175.80
1W+2.12%
1M-5.01%
3M+23.96%
6M+52.31%
1Y+9.06%
3Y+23.17%
5Y-31.70%
MAX-32.29%
Fundamentals
as of 26/10/2026- Market cap
- $10.17B
- Shares out
- 56.44M
- P/E (trailing)
- 244.78
- P/E (forward)
- 65.61
- EPS (trailing)
- 0.74
- Dividend yield
- 0.00%
- Beta
- 1.08
- Profit margin
- 5.29%
- P/B
- 4.81
- Return on equity
- 1.97%
SEC financial statements
59 quarterly and 17 annual periods through 30/06/2026.
Details
- Ticker
- RGEN
- Index
- SP400
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 26/10/2026.
Tracked by Congress
2 filers · 0 on watchlist · 3 buys · 4 sells · R: 7
- 31/10/2025Lisa McClainSellRepligen Corporation - Common Stock$1,001–$15,000
- 30/10/2025Lisa McClainSellRepligen Corporation - Common Stock$1,001–$15,000
- 30/10/2025Lisa McClainBuyRepligen Corporation - Common Stock$1,001–$15,000
- 22/07/2025Lisa McClainBuyRepligen Corporation - Common Stock$1,001–$15,000
- 17/06/2025Lisa McClainSell+Repligen Corporation - Common Stock$1,001–$15,000
- 11/06/2025Lisa McClainBuyRepligen Corporation - Common Stock$1,001–$15,000
- 07/04/2025Jefferson ShreveSellRepligen Corporation - Common Stock$15,001–$50,000